DEALS: Thermo Electron buys Fisher Scientific International for $10.6B

DEALS

WHO

WITH

WHAT

SCOOP

Thermo Electron

Fisher Scientific International

$10.6B buyout

Thermo Electron has agreed to buy Fisher Scientific International in a $10.6 billion stock deal, creating a major force in the laboratory supply business.

Merck

GlycoFi and Abmaxis

$480M buyout

Drug giant Merck has acquired two biotechs: GlycoFi for $400M and Abmaxis for $80 million.

Biogen Idec

Conforma Therapeutics

$150M buyout, $100M development deal

Biogen Idec is paying $150M up front to buy Conforma Therapeutics and will pay up to $100Mmore based on the success of Conforma's pipeline of cancer therapies.

Qiagen

Gentra Systems

$38M buyout

The Dutch molecular diagnostics company Qiagen has struck a deal to buy Minneapolis-based Gentra Systems for $38M in cash.

Atrium Biotechnologies

Amisol

$6M buyout

Atrium Biotechnologies is buying personal care products maker Amisol for $6M.

Human Genome Sciences

BioMed Realty

$425 million sale/leaseback deal

HGS has inked a $425M sale/leaseback deal with BioMed Realty on its lab, manufacturing and headquarters facilities.

AstraZeneca

Abraxis BioScience

$200M promotion deal, $350M sale

The companies will share the promotional rights to the cancer drug Abraxane. AZ also announced it will sell its anesthetic and analgesic products to Abraxane for $350M.

SkyePharma

Kos Pharmaceuticals

$165M licensing deal

SkyePharma has inked a $165M licensing deal with Kos Pharmaceuticals for the U.S. marketing rights to Flutiform for asthma. SkyePharma has been seeking a partner on the drug for three years.

Astellas Pharma

Ilypsa

$92M licensing deal

Astellas will pay $92M for the Japanese rights to Ilypsa for a Phase I experimental drug for hyperphosphatemia.

Astellas Pharma

FibroGen

$465M development deal

Astellas will pay $465M in developmental milestones for two of FibroGen's experimental drugs and invest $50M in FibroGen.

Akorn

Fidia Farmaceutici

Development deal

Akorn has signed a deal with Italy's Fidia Farmaceutici to develop four ANDA products.

PPD

PDL BioPharma

Development deal

PPD has struck a deal to develop biomarkers for PDL BioPharma.

Pfizer

Monogram Biosciences

$25M investment

Pfizer will invest $25M into Monogram Biosciences and will collaborate on Monogram's Co-Receptor Tropism Assay.

PerkinElmer

Spectral Genomics

Acquisition

PerkinElmer has acquired the screening and diagnostics company Spectral Genomics for an undisclosed amount.

Sigma-Aldrich

Iropharm

Acquisition

Sigma-Aldrich has acquired Iropharm's custom chemical synthesis facility in Ireland.